Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Asia

$500 SAVINGS END IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Dr. Lei Guo, Ph.D.
Senior Director, CRO Services at Wuxi Biologics, China
Speaker

Profile

Dr. Lei Guo leads the Protein Analytical Chemistry group in the CRO Services Department at WuXi Biologics. Her team specializes in comprehensive analytical testing of monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), and fusion proteins during drug discovery and optimization stages, employing Mass Spectrometry and physicochemical & biophysical analyses. With over 16 years of experience in bioanalysis, Dr. Guo has held diverse roles at Pfizer, Sanofi, and MSD, contributing to target identification, lead optimization, drug development, and CMC-stage analytical support.

Agenda Sessions

  • Early-Stage Developability Assessment for Bispecific Antibody Lead Optimization and Selection

    11:00